Total Funding
63
58
Total FundingSeries B raised
Growth Score
-8 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
206361
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
- Thomas Aaberg: Chief Medical Officer (CMO)
Richard Small: Chief Executive Officer & Board Member
About the Company
Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases–including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.
